Croda International - Britains Most Admired Company for Innovation
Yorkshire-based Croda International, manufacturers of speciality chemical ingredients that enhance everyday consumer and industrial products, has just been awarded first place in the innovation segment, second in the chemical sector category and eighth place overall in the 2014 Britain’s Most Admired Companies Awards.
The Management Today awards are the largest awards of their kind in the UK; they highlight corporate reputation by recognising key factors critical to business success, with winners identified by means of peer review.
Steve Foots, Chief Executive of Croda said: “To be named Britain’s most Innovative Company is a fantastic accolade and we are hugely proud to collect this award. Innovation runs through every part of our business and for this to be recognised by industry peers, and the investment community, is testament to the dedication and hard work of our employees across the globe.”
Organisations are scored against nine performance areas; from quality of management, financial soundness and quality of goods and services, to the ability to attract, develop and retain top talent, the capacity to innovate and commitment to community and environmental responsibility. Opinions on these areas are sought from more than 200 Board members at some of the UK’s largest companies, as well as analysts and City commentators.
Commenting on the results, Matthew Gywther, editor of Management Today said; “Croda took the 2014 criteria award for Capacity to Innovate, in recognition of its world-class reputation for generating new ideas for its customers and bringing them to market.
“Researched by Prof Mike Brown and his team at Birmingham City University, and with a history dating back over 20 years, Britain's Most Admired Companies provides a fascinating insight into that most hard-won of intangible assets, corporate reputation.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance